Clinical trials
Recruiting Alzheimer Disease trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2021 | 3 |
| 2024 | 2 |
| 2025 | 8 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 3 |
| Washington University School of Medicine | 3 |
| Hoffmann-La Roche | 2 |
| Celgene | 1 |
| Center for Eye Research Australia | 1 |
| Eidos Therapeutics, a BridgeBio company | 1 |
| Eli Lilly and Company | 1 |
| GlaxoSmithKline | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Monash University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 19 |
| Dementia | 12 |
| Cognitive Dysfunction | 5 |
| Neurodegenerative Diseases | 3 |
| Amyloid Neuropathies, Familial | 1 |
| Amyloidosis | 1 |
| Brain Diseases | 1 |
| Cardiomyopathies | 1 |
| Central Nervous System Diseases | 1 |
| Dementia, Vascular | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.